Why albumin may still work

Wiener Klinische Wochenschrift

Volumn 116, Issue 9-10, 2004, Pages 283-285

  Groeneveld, Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fluid therapy; Hypoalbuminemia; Hypovolemia; Plasma colloid osmotic pressure; Shock

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; EDITORIAL; HOMEOSTASIS; HYPOALBUMINEMIA; HYPOVOLEMIA; MULTIPLE ORGAN FAILURE; ONCOTIC PRESSURE; SEPTIC SHOCK;

EID: 3042694218     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03040896     Document Type: Editorial

References (24)

1. Groeneveld ABJ (2000) Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? Crit Care 4: S16-S20
2. Bossink AWJ, Groeneveld ABJ, Hack CE, Thijs LG (1998) Prediction of mortality in febrile medical patients. How useful are systemic inflammatory response syndrome and sepsis criteria? Chest 113: 1533-1541
3. Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 317: 235-240
4. Wilkes MM, Navckis RJ (2001) Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 135: 149-164
5. Alderson P, Bunn F, Lefebvre C, Li WP, Roberst I, Schierhout G (2002) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 1: CD001208
6. Haynes GR, Navickis RJ, Wilkes MM (2003) Albumin administration - what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 20: 771-793
7. Vincent JL, Dubois M-J, Navickis RJ, Wilkes MM (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237: 319-334
8. Wilkes MM, Navickis RJ, Sibbald WJ (2001) Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 72: 527-533
9. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruizdel-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403-409
10. Mimoz O, Soreda S, Padoin C, Tod M, Petitjean O, Benhamou D (2000) Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia. Anesthesiology 93: 735-743
11. Sen S, Jalan R, Williams R (2003) Liver failure: basis pof benefit of therapy with the molecular adsorbents recirculating system. Intern J Biochem Cell Biol 35: 1306-1311
12. Chalasani N, Gorski JC, Horlander JC, Craven R, Hoen H, Maya J, Brater DC (2001) Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12: 1010-1016
13. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge MC (1998) Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 95: 459-465
14. Horstick G, Lauterbach M, Kempf T, Ossendorf M, Kopacz L, Heimann A, Lehr H-A, Bhakdi S, Horstick M, Meyer J, Kempski O (2001) Plasma protein loss during surgery: beneficial effect of albumin substitution. Shock 16: 9-14
15. Moran EC, Kamiguti AS, Cawley JC, Pettitt AR (2002) Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic laekaemia. Br J Haematol 116: 316-328
16. Powers KA, Kapus A, Khadaroo RG, He R, Marshall JC, Lindsay TF, Rotstein OD (2003) Twenty-five percent albumin prevents lung injury forllowing shock/resuscitation. Crit Care Med 31: 2355-2363
17. Gum ET, Swanson RA, Alano C, Liu J, Hong S, Weinstein PR, Panter SS (2004) Human serum albumin and its N-terminal tetrapeptide (DAHK) block oxidant-induced neuronal death. Stroke 35: 591-596
18. Boldt J, Müller M, Heesen M, Neumann K, Hempelmann GG (1996) Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24: 385-390
19. Jones DT, Ganehaguru K, Anderson RJ, Jackson TR, Bruckdorfer KR, Low SY, Palmqvist L, Prentice HG, Hoffbrand AV, Mehta AB, Wickremasinghe RG (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 101: 3174-3180
20. Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, Van Nieuwenhuijze AE, Van Mierlo GJ, Eerenberg AJ, Lammle B, Hack CE (2003) Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 31: 1947-1951
21. Martin GS, Mangialardi RJ, Wheeler AP, DUpont WD, Morris JA, Bernard GR (2002) Albumin and furosemide therapy in hypoproteinemic pateitns with acute lung injury. Crit Care Med 30: 2175-2182
22. Vincent J-L, Wilkes MM, Navickis RJ (2003) Safety of human albumin-serious adverse events reported worldwide in 1998-2000. Br J Anaesthesia 91: 625-630
23. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA (2003) Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 123: 1853-1857
24. Veneman ThF, Oude Nijkhuis J, Woittiez AJJ (2004) Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial. In this issue of Wien Klin Wochenschr 116: 305-309